Law ministry advises govt against notifying drug price increases
ISLAMABAD: The government has been told to withhold a drug price revision notification by the Law Division regarding change in prices of life-saving drugs.
This...
Oxfam’s damning report puts multinational pharma companies in the dock over tax evasion
Tax Dodgers: In seven developing countries, firms appeared to avoid an estimated $112m in taxes every year
ISLAMABAD: Oxfam International’s damning report confirmed sustained allegations...
AGP Ltd raises Rs2.8 bn in IPO
KARACHI: AGP Limited, a part of OBS Group, the 8th largest Pharmaceutical Group in Pakistan, successfully raised Rs2.8 billion from foreign, local institutional investors...
Pak pharma industry suffers from government’s shackles
A thriving sector in Pakistan’s economy, pharmaceuticals is a $3.2 billion industry, growing at 15% annually, while its exports now at $US200 million are...
Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh
Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh.
Clarifying its position, the company stated,...
Senate panel alarmed as medicine prices jump 32% after price controls lifted
Health ministry reports some essential drugs have doubled in cost, prompting inquiry into deregulation impact; Pharmaceutical Manufacturers Association disputes the official figures
Govt backs PPMA’s expansion plans, discusses roadmap for $3 billion pharma export target by 2028
PharmEx Pakistan platform set to drive pharmaceutical exports to $3 billion in three years, and $10 billion over the next five years
In the first quarter after deregulation, pharma sector revenue up by 25%
The increase in revenue is driven mostly by price increases as drug manufacturers can finally raise prices based on business need and rising costs instead of regulatory fiat
PSW, DRAP launch digital certificates to boost pharmaceutical exportsÂ
Alongside Digital Certificate of Pharmaceutical Product, DRAP Clearance Gateway now offers Free Sale Certificate, Good Manufacturing Practice Certificate, and No Objection Certificate for exports; initiative to enhance regulatory efficiency
Can Hamdard thrive in the era of the millennial consumer?
It is an ad that relies on contrasts: a product as traditionally Pakistani as Hamdard’s Rooh Afza being consumed by non-Pakistanis in New York’s...
UK report claims Pakistan’s Covid-19 medicine enough for national demand
Pakistan, along with India, is the only one among developing countries to have effectively stored enough of Remdesivir to meet their national demands of...
Haleon Pakistan targets expansion to 19 countries, aims for 10% export sales share
Haleon plans to boost exports and local manufacturing, with focus on Vietnam, Philippines and local sourcing to reduce import reliance
Searle Company to divest entire stake in Searle Pakistan Limited
Board approves disposal of 100% shareholding; negotiations for terms underway
Citi Pharma enters into supply agreement with India’s Murli Krishna PharmaÂ
Murli Krishna Pharma will supply high-quality Active Pharmaceutical Ingredients (APIs) and products exclusively to Citi Pharma in Pakistan
Pharma sector thrives with 21.79% growth amid economic stagnation
Deregulation policy drives record sales, but patients face rising costs
